Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1490, 2005-01, pp. : 13-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Docetaxel regimen improves survival in early breast cancer
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :
TAC regimen improves survival in early breast cancer
Inpharma, Vol. 1, Iss. 1424, 2004-01 ,pp. :
In defence of trastuzumab for early breast cancer
Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. :
Trastuzumab prolongs survival in metastatic breast cancer
Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. :
Trastuzumab without an anthracycline: better for early breast cancer
Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. :